| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.0008 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |